| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Gene therapy for leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years. | Arch Ophthalmol | 2011 | 3.79 |
| 2 | Human CRB1-associated retinal degeneration: comparison with the rd8 Crb1-mutant mouse model. | Invest Ophthalmol Vis Sci | 2011 | 1.69 |
| 3 | Retinal disease in Rpe65-deficient mice: comparison to human leber congenital amaurosis due to RPE65 mutations. | Invest Ophthalmol Vis Sci | 2010 | 0.95 |